Twenty-eight loci that influence serum urate levels: Analysis of association with gout

Annals of the Rheumatic Diseases

Volumn 75, Issue 1, 2016, Pages 124-130

  Phipps Green, A J ^a   Merriman, M E ^a   Topless, R ^a   Altaf, S ^a   Montgomery, G W ^b   Franklin, C ^c   Jones, G T ^a   Van Rij, A M ^a   White, D ^d   Stamp, L K ^e   Dalbeth, N ^c   Merriman, T R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC ANION TRANSPORTER 4; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR MAF; URATE; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CARRIER PROTEIN; HLF PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IGF1R PROTEIN, HUMAN; INHBC PROTEIN, HUMAN; INHIBIN; MAF PROTEIN, HUMAN; MCT9 PROTEIN, HUMAN; MONOCARBOXYLATE TRANSPORTER; ORGANIC ANION TRANSPORTER; PDZK1 PROTEIN, HUMAN; PRKAG2 PROTEIN, HUMAN; SLC22A11 PROTEIN, HUMAN; SOMATOMEDIN RECEPTOR; TRANSCRIPTION FACTOR C MAF; URIC ACID;

ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE CLASSIFICATION; EFFECT SIZE; EUROPEAN; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GOUT; HLF GENE; HUMAN; IGF1R GENE; INHBC GENE; MAF GENE; MAJOR CLINICAL STUDY; MAORI (PEOPLE); NEW ZEALAND; PDZK1 GENE; POLYNESIAN; PRIORITY JOURNAL; PRKAG2 GENE; SLC16A9 GENE; SLC22A11 GENE; URIC ACID BLOOD LEVEL; BLOOD; GENETICS; META ANALYSIS; OCEANIC ANCESTRY GROUP;

AMP-ACTIVATED PROTEIN KINASES; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GOUT; HUMANS; INHIBIN-BETA SUBUNITS; MONOCARBOXYLIC ACID TRANSPORTERS; NEW ZEALAND; OCEANIC ANCESTRY GROUP; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; PROTO-ONCOGENE PROTEINS C-MAF; RECEPTORS, SOMATOMEDIN; URIC ACID;

EID: 84954318501     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205877     Document Type: Article

References (29)

1. Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
2. Yang Q, Köttgen A, Dehghan A, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010;3:523-30.
3. Flynn T, Phipps-Green A, Hollis-Moffatt JE, et al. Association analysis of the SLC22A11 (OAT4) and SLC22A12 (URAT1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther 2013;15:R220.
4. Hollis-Moffatt JE, Phipps-Green AJ, Chapman B, et al. The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther 2012;14:R92.
5. Hollis-Moffatt JE, Xu X, Dalbeth N, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum 2009;60:3485-92.
6. Köttgen A, Albrecht E, Teumer A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2013;45:145-54.
7. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet 2010;19:4813-19.
8. Wang J, Liu S, Wang B, et al. Association between gout and polymorphisms in GCKR in male Han Chinese. Hum Genet 2012;131:1261-5.
9. Urano W, Taniguchi A, Inoue E, et al. Effect of genetic polymorphisms on development of gout. J Rheumatol 2013;40:1374-8.
10. Rasheed H, Phipps-Green A, Topless R, et al. Association of the LRP2 (megalin) gene with gout and non-additive interaction with alcohol consumption. Arthritis Res Ther 2013;15:R177.
11. Prasad P, Krishnan E. Filipino gout-a review. Arthritis Care Res 2014;66:337-43.
12. Winnard D, Wright C, Jackson G, et al. Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. NZ Med J 2013;126:53-64.
13. Winnard D, Wright C, Taylor WJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatol 2012;51:901-9.
14. Taylor W. Diagnosis of gout: considering clinical and research settings. Curr Rheumatol Rev 2011;7:97-105.
15. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
16. Jones GT, Bown MJ, Gretarsdottir S, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13. 3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet 2013;22:2941-7.
17. Roberts RL, Van Rij AM, Phillips LV, et al. Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. Atherosclerosis 2011;218:123-6.
18. Batt C, Phipps-Green A, Black MA, et al. Sugar-sweetened beverage consumption: A risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis 2014;73:2101-6.
19. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-7.
20. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
21. McAdams-DeMarco MA, Maynard JW, Baer AN, et al. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study. Ann Rheum Dis 2013;72:701-6.
22. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190-5.
23. Woodward OM, Köttgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 2009;106:10338-42.
24. Woodward OM, Tukaye DN, Cui J, et al. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Proc Natl Acad Sci USA 2013;110:5223-8.
25. Lange LA, Hu Y, Zhang H, et al. Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol. Am J Hum Genet 2014;94:233-45.
26. Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009;324: 387-9.
27. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011;43:1066-73.
28. Smemo S, Tena JJ, Kim K-H, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 2014;507:371-5.
29. Wu Y, Waite LL, Jackson AU, et al. Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet 2013;9:e1003379.